A study showed that knockdown of IDH1 by RNA interference reduced the proliferative capacity of NSCLC cells and significantly decreased in vivo xenograft tumor formation, suggesting that IDH1 may be a potential target in lung cancer (11). The gene discussed is IDH1; the disease is neoplasm.